Chloroform spill forces evacuation of building at Canisius College in Buffalo, New York

Posted on by Admin

Monday, August 11, 2008

Buffalo, New York —The Buffalo Fire Department and Police were called to a hazmat situation at Canisius College on Main Street after security reported that a one gallon glass container containing chloroform broke, spilling about a pint onto the floor of the college’s science building.

According to communications by firefighters, who arrived at around 8:20 a.m. (eastern time), the glass container spilled on the third floor in room 318. As a precaution the building was evacuated and East Delevan road between Main Street and Jefferson Avenues was closed to all vehicle and pedestrian traffic while crews worked to clean up the spill.

At about 9:15 hazmat crews entered the room and began to clean up the chemical “using kitty litter” and fans to air out the room. They then sealed the material in a five gallon container. At 9:23 a.m. firefighters stated that they no longer detected the chemical in the air and began to pack up their gear.

Officials for the college assessed the situation and decided to keep the building closed for the day. “At 8:22am this morning the Public Safety Department and Buffalo Fire Department responded to a report of a chemical spill on the third floor of the Health Science Center. As the building is cleaned, the Health Science Building will remain closed today and reopen tomorrow morning,” a college official said to Wikinews, adding they could not confirm the firefighter reports.

Firefighters believe the container containing the chemical was knocked over while someone working with maintenance was cleaning the floors.

There are no reports of injuries, but WKBW reports that the maintenance worker was taken to Sister’s of Saint Mercy’s hospital not far from the college for observation.

Chloroform is a common solvent used in chemistry laboratories. Minimal exposure can cause dizziness, headaches and fainting while prolonged exposure can cause liver and kidney damage. It is considered a hazardous material and environmentally unsafe. Banned as a consumer product since 1976 in the U.S., it was previously used in toothpaste, cough medicines and pharmaceuticals.

Retrieved from “https://en.wikinews.org/w/index.php?title=Chloroform_spill_forces_evacuation_of_building_at_Canisius_College_in_Buffalo,_New_York&oldid=1712707”
Posted in Uncategorized

Advocacy groups complain about 4parents.gov sex-ed website

Posted on by Admin

Tuesday, April 5, 2005The Sexuality Information and Education Council of the United States (SIECUS) has written a March 31 letter to Michael Leavitt, Secretary of Health and Human Services (HHS). The letter presents a number of complaints about the new HHS website for parents, called 4parents.gov.

An additional 145 advocacy groups have signed on to the letter, including notable liberal groups such as the American Civil Liberties Union (ACLU), Planned Parenthood, and the National Organization for Women (NOW).

Among the concerns expressed in the letter about the website:

  • It contains factual errors and outdated terminology.
  • It is politically biased, and only credits one non-governmental organization, the National Physicians Center for Family Resources (NPC), which the letter claims has “strong ties to right wing religious organizations like the California Family Council, Alabama Family Alliance, and Focus on the Family.”
  • It introduces anti-abortion language, such as referring to the developing fetus as an “unborn child” and defining that pregnancy begins at fertilization, rather than at implantation, the definition previously accepted by the HHS.
  • It also “does not address the needs of many youth, including sexually active youth, youth who have been or are being sexually abused, and lesbian, gay, bisexual, transgender, and questioning (LGBTQ) youth.”

SIECUS further requested that the site be “immediately taken down and that a formal review of its content and techniques for communication and behavioral learning be launched,” in which SIECUS and its related associations would be assisting.

According to the 4parents.gov website, ” 4Parents.gov is part of a new national public education campaign to provide parents with the information, tools and skills they need to help their teens make the healthiest choices.” Whether this implies that other websites or educational materials will be released in the near future was not made clear.

The site appeared to particularly focus on parent-child communication and the delivery of sex-ed information to parents in order to support that cause. The stated goal of this campaign is improvement of public health through the reduction of sexually transmitted diseases (STDs) and other health-related issues that affect teens.

Retrieved from “https://en.wikinews.org/w/index.php?title=Advocacy_groups_complain_about_4parents.gov_sex-ed_website&oldid=4626958”
Posted in Uncategorized

Ways A Professional, Who Deals With Real Estate Sales In Oceanside Ny Can Help When Looking For A New Home

Posted on by Admin

byadmin

If you are looking for a new home for you and your family, it can be helpful to enlist the aid of a professional who handles Real Estate Sales in Oceanside NY. By doing this, you will often find it is easier to find a home well suited for your needs in a timely and efficient manner.

Many people today may feel they can locate and buy their own home as well as a professional. While there are a number of resources online to help you in trying to accomplish this, often it can still be a struggle. Most online resources are spread out, and this requires a great deal of work to gather information. In addition, online sources only include homes that are officially for sale. Because of this, it is difficult to get the upper hand on homes coming up for sale in the near future.

Using a professional who works in Real Estate Sales in Oceanside NY can help in eliminating these issues. Most real estate professionals have access to listings and other services a buyer may not be able to obtain online. They also subscribe to local listings services, a buyer may not be willing to invest in. This can make it much easier for the professional to know what is available for sale in the area.

Since a professional will work with a network of other agents, they often will share information about potential homes to be listed in the near future. This can be a great help in making sure a client can see a potential home and make an offer before someone else does. These types of leads can be invaluable to a person looking for a home designed to fit their specific needs.

Anyone who is considering purchasing a new home will find there are many ways a professional can help make the task of finding and buying a home much easier. This can be a great benefit in helping to make this type of complicated purchase proceed more smoothly. For more information on how a professional can assist you with your home buying needs, please Click Here.

Commonwealth Bank of Australia CEO apologies for financial planning scandal

Posted on by Admin

Thursday, July 3, 2014

Ian Narev, the CEO of the Commonwealth Bank of Australia, this morning “unreservedly” apologised to clients who lost money in a scandal involving the bank’s financial planning services arm.

Last week, a Senate enquiry found financial advisers from the Commonwealth Bank had made high-risk investments of clients’ money without the clients’ permission, resulting in hundreds of millions of dollars lost. The Senate enquiry called for a Royal Commission into the bank, and the Australian Securities and Investments Commission (ASIC).

Mr Narev stated the bank’s performance in providing financial advice was “unacceptable”, and the bank was launching a scheme to compensate clients who lost money due to the planners’ actions.

In a statement Mr Narev said, “Poor advice provided by some of our advisers between 2003 and 2012 caused financial loss and distress and I am truly sorry for that. […] There have been changes in management, structure and culture. We have also invested in new systems, implemented new processes, enhanced adviser supervision and improved training.”

An investigation by Fairfax Media instigated the Senate inquiry into the Commonwealth Bank’s financial planning division and ASIC.

Whistleblower Jeff Morris, who reported the misconduct of the bank to ASIC six years ago, said in an article for The Sydney Morning Herald that neither the bank nor ASIC should be in control of the compensation program.

Retrieved from “https://en.wikinews.org/w/index.php?title=Commonwealth_Bank_of_Australia_CEO_apologies_for_financial_planning_scandal&oldid=3869292”
Posted in Uncategorized

Market maker Bernard L. Madoff arrested in $50B ‘giant Ponzi scheme’

Posted on by Admin
 Correction — January 10, 2009 This article incorrectly states that Mr Madoff attended Hofstra University Law School. His education was actually with Hofstra College, which he graduated from in 1960. 

Friday, December 12, 2008

Top broker and Wall Street adviser Bernard L. Madoff, aged 70, was arrested and charged by the FBI on Thursday with a single count of securities fraud, also known as stock fraud and investment fraud. He allegedly told senior employees of his firm on Wednesday that his $50 billion business “is all just one big lie” and that it was “basically, a giant Ponzi scheme (since at least 2005).” Mr. Madoff faces up to 20 years imprisonment and a fine of up to $5 million. FBI agent Theodore Cacioppi said Mr. Madoff’s investment advisory business had “deceived investors by operating a securities business in which he traded and lost investor money, and then paid certain investors purported returns on investment with the principal received from other, different investors, which resulted in investors’ losses of approximately $50 billion dollars.”

The former chairman of the Nasdaq Stock Market is also the founder and primary owner of Bernard L. Madoff Investment Securities LLC, the closely-held market-making firm he launched in 1960. The firm is one of the top market maker firms on Wall Street. He founded his family firm with an initial investment of $5,000, after attending Hofstra University Law School. He saved the money earned from a job lifeguarding at Rockaway Beach in Queens and a part time job installing underground sprinkler systems.

A force in Wall Street trading for nearly 50 years, he has been active in the National Association of Securities Dealers (NASD), a self-regulatory organization for the U.S. securities industry. His firm was one of the five most active firms in the development of the NASDAQ, having been known for “paying for order flow,” in other word paying a broker to execute a customer’s order through Madoff. He argued that the payment to the broker did not alter the price that the customer received. He ran the investment advisory as a secretive business, however.

Dan Horwitz, counsel of Mr. Madoff, in an interview, said that “he is a longstanding leader in the financial-services industry with an unblemished record; he is a person of integrity; he intends to fight to get through this unfortunate event.” Mr. Madoff was released on his own recognizance on the same day of his arrest, after his 2 sons turned him in, and posting $10 million bail secured by his Manhattan apartment. Without entering any plea, the Court set the preliminary hearing for January 12.

Madoff’s hedge fund scheme may rank among the biggest fraud in history. When former energy trading giant Enron filed for bankruptcy in 2001, one of the largest at the time, it had $63.4 billion in assets. The scheme would dwarf past Ponzis, and it would further be nearly five times the telecommunication company WorldCom fraud and bankruptcy proceedings in 2002.

The Securities and Exchange Commission filed a separate civil suit on Thursday against Bernard L. Madoff Investment Securities and its eponymous founder Mr. Madoff. It was docketed as “U.S. v. Madoff,” 08-MAG-02735, by the U.S. District Court for the Southern District of New York (Manhattan). SEC, New York associate director of enforcement, Andrew M. Calamari, asked the judge to issue seizure orders on the firm and its assets, and appoint a receiver. The SEC pleads, among others, that “it was an ongoing $50 billion swindle; our complaint alleges a stunning fraud that appears to be of epic proportions.” It further accused the defendant of “paying returns to certain investors out of the principal received from other, different investors” for years. Madoff’s hedge fund business had previously claimed to have served between 11 and 25 clients and had $17.1 billion in assets under management. But virtually all of the assets were missing.

United States District Court for the Southern District of New York Louis L. Stanton on Thursday appointed Lee Richards, a Manhattan lawyer, as the firm’s receiver. A hearing is set for Friday, for a ruling on the SEC’s petition to grant plenary powers to the receiver over the entire firm, and an absolute asset sequestration.

Doug Kass, president of hedge fund Seabreeze Partners Management said that “this is a major blow to confidence that is already shattered — anyone on the fence will probably try to take their money out.”

Retrieved from “https://en.wikinews.org/w/index.php?title=Market_maker_Bernard_L._Madoff_arrested_in_$50B_%27giant_Ponzi_scheme%27&oldid=4561285”
Posted in Uncategorized

The Non Invasive Cancer Diagnostics Market Is Projected To Grow At An Annualized Rate Of ~20%, Till

Posted on by Admin

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this link

Key Market Insights

  • Presently, nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world
  • Several modern diagnostic tests claim to be capable of offering results in relatively short time periods, thereby, facilitating early diagnosis that is particularly beneficial in the treatment of different types of cancers
  • Over time, big pharma players have initiated product development programs, having invested significant capital, time and effort, on non-invasive diagnostic solutions for use across different oncological indications
  • Investors, having realized the untapped opportunity within this emerging segment of the cancer diagnostics market, have invested over USD 3 billion across 120 instances in the period between 2015 and 2019
  • The growing interest in this field is also reflected in the partnership activity; deals inked in the recent past are focused on a diverse range of tumor markers, involving both international and indigenous stakeholders
  • The projected future opportunity is anticipated to be driven by increasing patient population and distributed across various disease indications and application areas across key geographies
  • These tests are capable of detecting diverse tumor markers that cater to the needs of different stakeholders; in fact, opinions of industry experts confirm the vast potential of liquid biopsies in disease diagnosis / monitoring

For more information, please visit

Table of Contents

  1. PREFACE

1.1. Scope of the Report

1.2. Research Methodology

1.3. Chapter Outlines

  1. EXECUTIVE SUMMARY
  1. INTRODUCTION

3.1. Chapter Overview

3.2. Cancer Statistics and Burden of the Disease

3.3. Importance of Early Cancer Detection

3.4. Cancer Screening and Diagnosis

3.5. Conventional Invasive Cancer Diagnostic Tests

3.5.1. Biopsy

3.5.1.1. Fine Needle Aspiration Biopsy

3.5.1.2. Core Needle Biopsy

3.5.1.3. Vacuum-Assisted Biopsy

3.5.1.4. Image-Guided Biopsy

Press Release: Variation 2 (Format 3)

3.5.1.5. Sentinel Node Biopsy

3.5.1.6. Surgical Biopsy

3.5.1.7. Endoscopic Biopsy

3.5.1.8. Bone Marrow Biopsy

3.5.2. Endoscopy

3.6. Need for Non-Invasive Approaches

3.7. Liquid Biopsy: Diagnosing Circulating Biomarkers

3.7.1. Circulating Tumor Cells

3.7.2. Circulating Tumor DNA

3.7.3. Exosomes

3.8. Costs and Benefits Associated with Liquid Biopsy and Non-Invasive Tests

3.9. Emerging Trends in Intellectual Property Related to Non-Invasive Cancer Diagnostics

3.10. Challenges Associated with Non-Invasive Cancer Diagnostics

3.11. Future Perspectives

  1. NON-INVASIVE CANCER SCREENING AND DIAGNOSIS

4.1. Chapter Overview

4.2. Diagnostic Imaging

4.2.1. Magnetic Resonance Imaging (MRI)

4.2.2. Mammography

4.2.3. Bone Scan

4.2.4. Computerized Tomography (CT) Scan

4.2.5. Integrated Positron Emission Tomography (PET)-CT Scan

4.2.6. Ultrasound

4.2.7. X-ray Radiography (Barium Enema)

4.3. Screening Assays

4.3.1. Circulating Tumor Marker Test

4.3.2. Digital Rectal Exam (DRE)

4.3.3. Fecal Occult Blood Test (FOBT)

4.3.4. Multigated Acquisition (MUGA) Scan

4.3.5. Papanicolaou Test and Human Papilloma Virus Test

4.4. Advanced Non-Invasive Approaches

4.4.1. Cytogenetic / Gene Expression Studies

4.4.2. Molecular Signature-based Non-Invasive Methods

4.4.3. Saliva-based Oral Cancer Diagnostics

4.4.4. Vital Staining

4.4.5. Optical Biopsy

4.4.6. Other Diagnostic Techniques

  1. MARKET LANDSCAPE

5.1. Chapter Overview

5.2. Liquid Biopsy Products: List of Developers

5.2.1. Analysis by Year of Establishment

5.2.2. Analysis by Company Size and Geographical Location

5.2.3. Leading Players

5.2.4. Analysis by Geography

5.3. Liquid Biopsy Products: List of Available / Under Development Products

5.3.1. Analysis by Status of Development

5.3.2. Analysis by Type of Product

5.3.3. Analysis by Application Area

Press Release: Variation 2 (Format 3)

5.3.4. Analysis by Target Cancer Indication

5.3.5. Analysis by Type of Tumor Marker

5.3.6. Analysis by End User

5.3.7. Analysis by Turnaround Time

5.4. Liquid Biopsy Products: List of Other Products, Kits and Consumables

5.5. Liquid Biopsy Products: List of Contract Service Providers

  1. COMPANY PROFILES

6.1. Chapter Overview

6.2. Amoy Diagnostics

6.2.1. Company Overview

6.2.2. Financial Information

6.2.3. Liquid Biopsy Product Portfolio

6.2.4. Recent Developments and Future Outlook

6.3. DiaCarta

6.3.1. Company Overview

6.3.2. Liquid Biopsy Product Portfolio

6.3.3. Recent Developments and Future Outlook

6.4. HaploX

6.4.1. Company Overview

6.4.2. Liquid Biopsy Product Portfolio

6.4.3. Recent Developments and Future Outlook

6.5. NeoGenomics

6.5.1. Company Overview

6.5.2. Financial Information

6.5.3. Liquid Biopsy Product Portfolio

6.5.4. Recent Developments and Future Outlook

6.6. QIAGEN

6.6.1. Company Overview

6.6.2. Financial Information

6.6.3. Liquid Biopsy Product Portfolio

6.6.4. Recent Developments and Future Outlook

6.7. Swift Biosciences

6.7.1. Company Overview

6.7.2. Liquid Biopsy Product Portfolio

6.7.3. Recent Developments and Future Outlook

6.8. Sysmex Inostics

6.8.1. Company Overview

6.8.2. Liquid Biopsy Product Portfolio

6.8.3. Recent Developments and Future Outlook

6.9. Thermo Fisher Scientific

6.9.1. Company Overview

6.9.2. Financial Information

6.9.3. Liquid Biopsy Product Portfolio

6.9.4. Recent Developments and Future Outlook

  1. PARTNERSHIPS AND COLLABORATIONS

7.1. Chapter Overview

Press Release: Variation 2 (Format 3)

7.2. Partnership Models

7.3. List of Partnerships and Collaborations

7.3.1. Analysis by Year of Partnership

7.3.2. Analysis by Type of Partnership

7.3.3. Analysis by Type of Tumor Marker

7.3.4. Analysis by Target Cancer Indication

7.3.5. Analysis by Type of Partner

7.3.6. Most Active Players: Analysis by Number of Partnerships

7.3.7. Regional Analysis

7.3.7.1. Intercontinental and Intracontinental Agreements

  1. FUNDING AND INVESTMENT ANALYSIS

8.1. Chapter Overview

8.2. Types of Funding

8.3. List of Funding and Investment Instances

8.3.1. Analysis by Number of Funding Instances

8.3.2. Analysis by Amount Invested

8.3.3. Analysis by Type of Funding

8.3.4. Analysis by Target Cancer Indication

8.3.5. Analysis by Type of Tumor Marker

8.3.6. Most Active Players: Analysis by Amount Invested

8.3.7. Most Active Investors: Analysis by Number of Funding Instances

8.3.8. Regional Analysis by Amount Invested

8.4. Concluding Remarks

  1. LIQUID BIOPSY: INITIATIVES OF BIG PHARMA PLAYERS

9.1. Chapter Overview

9.2. Top Pharmaceutical Companies

9.2.1. Analysis by Status of Development

9.2.2. Analysis by Type of Tumor Marker

9.2.3. Analysis by Application Area

9.2.4. Analysis by Target Cancer Indication

  1. KEY ACQUISITION TARGETS

10.1. Chapter Overview

10.2. Scope and Methodology

10.3. Scoring Criteria and Key Assumptions

10.4. Potential Strategic Acquisition Targets in North America

10.5. Potential Strategic Acquisition Targets in Europe

10.6. Potential Strategic Acquisition Targets in Asia-Pacific / Rest of the World

10.7. Concluding Remarks

  1. OTHER NON-INVASIVE CANCER DIAGNOSTICS

11.1. Chapter Overview

11.2. Non-Blood-based Biomarker Detection Tests

11.3. FOBT and Fecal Immunochemical Tests (FIT)

11.4. Pigmented Lesion Assays

11.5. Stool DNA (sDNA)-based Tests

11.6. Volatile Organic Compound (VOC) Detection Tests

11.7. Other Non-Invasive Cancer Diagnostics: Market Landscape

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS

12.1. Chapter Overview

12.2. Key Assumptions and Forecast Methodology

Press Release: Variation 2 (Format 3)

12.3. Global Non-Invasive Cancer Diagnostics Market, 2019-2030

12.3.1. Global Liquid Biopsy Market, 2019-2030

12.3.1.1. Global Liquid Biopsy Market: Distribution by Application Area, 2019-2030

12.3.1.1.1. Global Liquid Biopsy Market for Early Diagnosis, 2019-2030

12.3.1.1.2. Global Liquid Biopsy Market for Patient Monitoring, 2019-2030

12.3.1.1.3. Global Liquid Biopsy Market for Recurrence Monitoring, 2019-2030

12.3.1.2. Global Liquid Biopsy Market: Distribution by Target Cancer Indication, 2019-2030

12.3.1.2.1. Global Liquid Biopsy Market for Breast Cancer, 2019-2030

12.3.1.2.2. Global Liquid Biopsy Market for Lung Cancer, 2019-2030

12.3.1.2.3. Global Liquid Biopsy Market for Colorectal Cancer, 2019-2030

12.3.1.2.4. Global Liquid Biopsy Market for Prostate Cancer, 2019-2030

12.3.1.2.5. Global Liquid Biopsy Market for Bladder Cancer, 2019-2030

12.3.1.2.6. Global Liquid Biopsy Market for Melanoma, 2019-2030

12.3.1.2.7. Global Liquid Biopsy Market for Gastric Cancer, 2019-2030

12.3.1.2.8. Global Liquid Biopsy Market for Pancreatic Cancer, 2019-2030

12.3.1.2.9. Global Liquid Biopsy Market for Ovarian Cancer, 2019-2030

12.3.1.3. Global Liquid Biopsy Market: Distribution by Type of Tumor Marker, 2019-2030

12.3.1.3.1. Global Liquid Biopsy Market for ctDNA, 2019-2030

12.3.1.3.2. Global Liquid Biopsy Market for cfDNA, 2019-2030

12.3.1.3.3. Global Liquid Biopsy Market for CTCs, 2019-2030

12.3.1.3.4. Global Liquid Biopsy Market for Exosomes, 2019-2030

12.3.1.3.5. Global Liquid Biopsy Market for Other Tumor Markers, 2019-2030

12.3.1.4. Global Liquid Biopsy Market: Distribution by Type of Analyte, 2019-2030

12.3.1.4.1. Global Liquid Biopsy Market for Blood, 2019-2030

12.3.1.4.2. Global Liquid Biopsy Market for Other Body Fluids, 2019-2030 (USD Billion)

12.3.1.5. Global Liquid Biopsy Market: Distribution by End User, 2019-2030

12.3.1.5.1. Global Liquid Biopsy Market for Hospitals, 2019-2030

12.3.1.5.2. Global Liquid Biopsy Market for Research Institutes, 2019-2030

12.3.1.5.3. Global Liquid Biopsy Market for Other End Users, 2019-2030

12.3.1.6. Global Liquid Biopsy Market: Distribution by Geography, 2019-2030

12.3.1.6.1. Liquid Biopsy Market in the US, 2019-2030

12.3.1.6.2. Liquid Biopsy Market in the UK, 2019-2030

12.3.1.6.3. Liquid Biopsy Market in Germany, 2019-2030

12.3.1.6.4. Liquid Biopsy Market in France, 2019-2030

12.3.1.6.5. Liquid Biopsy Market in Italy, 2019-2030

12.3.1.6.6. Liquid Biopsy Market in Spain, 2019-2030

12.3.1.6.7. Liquid Biopsy Market in Japan, 2019-2030

12.3.1.6.8. Liquid Biopsy Market in China, 2019-2030

12.3.1.6.9. Liquid Biopsy Market in India, 2019-2030

12.3.1.6.10. Liquid Biopsy Market in Australia, 2019-2030

12.3.2. Other Non-Invasive Cancer Diagnostics Market Forecast, 2019-2030

  1. SURVEY INSIGHTS

13.1. Chapter Overview

13.2. Company Specifics of Respondents

13.3. Designation of Respondents

13.4. Type of Product Portfolio

13.5. Types of Products / Services Offered

13.6. Application Area

Press Release: Variation 2 (Format 3)

13.7. Status of Development of the Products

13.8. Likely Market Size

  1. CONCLUSION

14.1. Timely Disease Detection and Subsequent Monitoring are Critical Elements of Patient Care

in the Field of Oncology

14.2. Introduction of Sophisticated Molecular Diagnostics has Facilitated Better Cancer

Management

14.3. Liquid Biopsy has Emerged as a Reliable Alternative to the Invasive Methods of Diagnosis

14.4. The Versatile and Patient Friendly Nature of these Diagnostic Tools Cater to a Wide Range

of Applications

14.5. The Interest is Gradually Rising with Participation of Several Start-ups Across Different

Geographies

14.6. In Addition to Liquid Biopsy, Development of Other Non-Invasive Tests will Further

Strengthen the Ongoing Innovation

14.7. Rising Venture Capital Support is Indicative of a Lucrative Future Potential

14.8. Primarily Led by Liquid Biopsy, the Non-Invasive Cancer Diagnostics Market has Emerged

as a Multi-Billion Dollar Market

  1. EXECUTIVE INSIGHTS

15.1. Chapter Overview

15.2. Interview Transcript: Shibichakravarthy Kannan, Founder & Chief Executive Officer,

Theranosis Life Sciences

15.3. Interview Transcript: Anton Iliuk, President and Chief Technology Officer, Tymora Analytical

Operations

15.4. Interview Transcript: Peter French, Strategic Technology Advisor, Sienna Cancer

Diagnostics

15.5. Interview Transcript: Joachim Fluhrer, Founder and Medical Director, Genostics

15.6. Interview Transcript: Brad Walsh, Chief Executive Officer, Minomic International

15.7. Interview Transcript: Catalina Vasquez, Chief Operating Officer, Nanostics

15.8. Interview Transcript: Burkhard Jansen, Chief Medical Officer, DermTech

15.9. Interview Transcript: Frank Szczepanski, President and CEO, IVDiagnostics

15.10. Interview Transcript: Riccardo Razzini, Sales and Marketing Manager, LCM Genect

15.11. Interview Transcript: Nathalie Bernard, Marketing Director, OncoDNA

15.12. Interview Transcript: Abizar Lakdawalla, Founder, Proxeom

15.13. Interview Transcript: Mark Li, CEO, Resolution Bioscience

15.14. Interview Transcript: Christer Ericsson, Chief Scientific Officer, iCellate Medical

15.15. Interview Transcript: Philippe Nore, CEO and Co-founder, MiNDERA

15.16. Interview Transcript: Jake Micallef, Chief Scientific Officer, VolitionRx

  1. APPENDIX 1: TABULATED DATA
  1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Andrea Muizelaar on fashion, anorexia, and life after ‘Top Model’

Posted on by Admin

Monday, November 26, 2007

In the 18 months since Andrea Muizelaar was crowned winner of the reality TV series Canada’s Next Top Model, her life has been a complete whirlwind. From working in a dollar store in her hometown of Whitby, Ontario, to modeling haute couture in Toronto, she had reached her dream of becoming a true Top Model.

But at what cost? Unknown to casual television viewers, Muizelaar had been enveloped in the eating disorder anorexia nervosa, which inevitably became too much for her to bear. She gave up modeling and moved back to Whitby, where she sought treatment for her disorder, re-entered college, and now works at a bank. Where is she now? Happy and healthy, she says.

Recently Andrea Muizelaar sat down with Wikinews reporter Mike Halterman in a candid interview that stretched to nearly two hours, as she told all about her hopes and aspirations, her battle with anorexia, and just what really happened on Canada’s Next Top Model.

Retrieved from “https://en.wikinews.org/w/index.php?title=Andrea_Muizelaar_on_fashion,_anorexia,_and_life_after_%27Top_Model%27&oldid=1408470”
Posted in Uncategorized

Hospitals declare “code red” in Wellington, New Zealand

Posted on by Admin

Thursday, July 19, 2007

The Capital & Coast District Health Board today issued a “code red” for two Wellington hospitals. Both Wellington Hospital and Kenepuru Community Hospital have a staff shortage of about 20 nurses, and the hospital is calling on any help available.

Dr Robyn Toomath, director of clinical support services at the Health Board, is calling for “any qualified nurses in the community who are between jobs, are on extended leave or are semi-retired, who might be able to help fill in, or to do some short term work for us.”

“As of today we are around 20 nurses down compared to our usual staffing levels, primarily due to illness” said Dr Toomath. “We have physical beds available, but we can’t admit patients unless there are appropriate levels of staff to safely resource those beds.”

The message to the general public was to “please save our Emergency Department for emergencies”, she said. “We want to be able to focus our Emergency Department resources on patients who genuinely need hospital-level care.”

Any qualified nurses who are willing to help at either of the two hospitals should contact Steve Crew in the Patient Services Coordination Unit, at the Capital and Coast District Health Board.

Retrieved from “https://en.wikinews.org/w/index.php?title=Hospitals_declare_%22code_red%22_in_Wellington,_New_Zealand&oldid=3480363”
Posted in Uncategorized

Montreal mayor Michael Applebaum arrested for corruption

Posted on by Admin

Tuesday, June 18, 2013

Michael Applebaum, the current interim mayor of Montreal, Québec, Canada, was arrested at about 6am local time (1000 UTC) yesterday morning by the Unité permanente anticorruption ((en))French language: ?Permanent Anti-Corruption Unit on fourteen charges including corruption, fraud, breach of trust, and conspiracy, including reportedly a C$50,000 bribe.

Commissioner Robert Lafrenière said the alleged illegal acts occurred between 2006 and 2011 and relate to two real-estate projects in the Côte des Neiges-Notre Dame de Grâce borough. The CBC indicated one of these projects was the borough’s new 15 million dollar sports complex. Applebaum is now one of several Québec mayors who have been accused of corruption in the past few years, including the previous Montreal mayor Gérald Tremblay and Laval Mayor Gilles Vaillancourt.

Several politicians are calling on Applebaum to resign, including Québec Premier Pauline Marois, to let the city continue on with its affairs. A few others, such as Coalition Avenir Québec leader François Legault, are suggesting to put the city on a trusteeship as Laval was a few weeks ago, but Municipal Affairs Minister Sylvain Gaudreault says this will not happen, as only a few people are implicated, unlike Laval, where nearly the entire city council was implicated.

Two other people were arrested on charges related to the same real-estate deals: Saulie Zajdel, former city councillor, on five charges; and Jean-Yves Bisson, a bourough official, on four charges.

A second interim minister is to be nominated for the rest of Tremblay’s term, until the next municipal election is held in November.

Retrieved from “https://en.wikinews.org/w/index.php?title=Montreal_mayor_Michael_Applebaum_arrested_for_corruption&oldid=1937630”
Posted in Uncategorized

Nursing Tops You Deserve

Posted on by Admin

By Amy Jarman

If you just had your baby you are no doubt unable to fit back into your pre-pregnancy clothes and not too excited about wearing your maternity clothes too much longer. Sure its fun to look pregnant when you are pregnant, but who wants to be asked when are you due at 3 weeks postpartum? Whats more, if you plan to nurse, the last thing you want to do is flash your postpartum belly to the world while trying to unhook a new nursing bra for your hungry baby. You deserve better than this for all the work you have been through in birthing and nurturing a newborn plus 9 months of pregnancy, so treat yourself to some fashionable but very useful nursing tops that make you feel pretty and make nursing on-the-go a much easier task.

Theres no need to wear a frumpy 2 fabric layer old-school nursing top in the middle of summer or ever. Now a-days there are a ton of cute and hip nursing top styles on the market that dont look a thing like a nursing top. Look for a neck style that flatters your face shape. This is a time to play up your neckline as well as your bust line while it is in full bloom. So pick a style that flatters your face and figure.

Olian Maternity has some great new styles to choose from this summer such as their Round Neck Maternity/Nursing top. This pretty lipstick shape empire waist top can be worn for either maternity or postpartum for nursing. The back sash tie makes it easily adjustable to your shape and the front pleats do wonders to disguise a postpartum belly while not tenting out. Attention is drawn to the pretty neckline, cap sleeves and fitted ruching empire waist style while the belly area is completely camouflaged. Nursing access is under the empire waist which makes nursing a breeze without showing any skin.

[youtube]http://www.youtube.com/watch?v=cdhLOIMltEc[/youtube]

Another great look is the deep V-neck top with a faux pick-a-boo cami to make discreet nursing easy the fabric lightweight cool for hot summer months. Take a look at Maternal Americas Combo Maternity/Nursing top which is cut extra long for style and comfort and could even be worn with leggings in early pregnancy and postpartum. The faux cami is a sailor stripe while the rest of the tunic is navy. The adjustable sash tie makes this style an easy fit for all stages of your bodys metamorphosis through pregnancy and nursing. The mock cami provides nursing access from the deep V-neck without you missing a beat to your busy day or prolonging a babys hungry cry.

If your maternity leave is over and you are ready to head back to the office but dont have a suitable top to wear, much less one that looks good on and fits your changing shape, then check out Japanese Weekends nursing tops which make for excellent transition wear to the office or out on the town in the evening. Their D&A (during and after) line of maternity/tops provide a lot of sophisticated styles in cool prints and solids. In particular, their D&A sleeves Sash Tie in pretty Teal is a great all-season look for any workplace. This top is a front cross-over empire waist design with a V-neck that hits high enough not to reveal cleavage while still flattering your shape. Nursing access can be made under the empire waist sash or above from the cross over front design. You can dress this top up or down for day or night.

Another great choice for work by Japanese Weekend is the D&A cami which comes in a variety of colors. Similarly this cami works great during and after pregnancy and nursing access is from under the empire waist stretch band which provides an overlay of fabric across the bust. The cami also has a stylish bottom band which works great for both a blooming belly (by keeping the fabric from tenting out) and for postpartum wear as the pleats work to disguise a postpartum belly. You can layer this cami under a jacket or cardigan for a sharp professional look or wear alone with pants for a more casual look in the evening. Many women find this cami so useful and flattering that they stock up on it in a variety of colors.

So whether you are a stay-at-home mom in need of better style or fit in your top selection or a professional on the go whos just had a baby, treat yourself to a few good transition wear tops to take you through the next several months in style and comfort.

About the Author: Amy Jarman is owner of TummyStyle.com selling maternity and

nursing clothes

&

nursing tops

by

Japanese Weekend

, Maternal America, Olian, BelaBumBum, Bravado, Bella Band and more!

Source:

isnare.com

Permanent Link:

isnare.com/?aid=558656&ca=Womens+Interest